 | • レポートコード：MRC2-11QY00282 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は循環バイオマーカーのグローバル市場について調査・分析したレポートです。種類別（循環DNA、循環腫瘍細胞、その他）市場規模、用途別（病院、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別循環バイオマーカーの競争状況、市場シェア ・世界の循環バイオマーカー市場：種類別市場規模 2015年-2020年（循環DNA、循環腫瘍細胞、その他） ・世界の循環バイオマーカー市場：種類別市場規模予測 2021年-2026年（循環DNA、循環腫瘍細胞、その他） ・世界の循環バイオマーカー市場：用途別市場規模 2015年-2020年（病院、医学研究センター、その他） ・世界の循環バイオマーカー市場：用途別市場規模予測 2021年-2026年（病院、医学研究センター、その他） ・北米の循環バイオマーカー市場分析：米国、カナダ ・ヨーロッパの循環バイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの循環バイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の循環バイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの循環バイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Becton, Dickinson and Company、GE Healthcare、Epigenomics AG、Agilent Technologies、Biocept、Affymetrix、Fluxion Biosciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Circulating Biomarker Market
The global Circulating Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Circulating Biomarker Scope and Market Size
Circulating Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Circulating Biomarker market is segmented into
Circulating DNA
Circulating Tumor Cells
Other
Segment by Application, the Circulating Biomarker market is segmented into
Hospital
Medical Research Center
Others
Regional and Country-level Analysis
The Circulating Biomarker market is analysed and market size information is provided by regions (countries).
The key regions covered in the Circulating Biomarker market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Circulating Biomarker Market Share Analysis
Circulating Biomarker market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Circulating Biomarker business, the date to enter into the Circulating Biomarker market, Circulating Biomarker product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
1 Study Coverage
1.1 Circulating Biomarker Product Introduction
1.2 Market Segments
1.3 Key Circulating Biomarker Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Circulating Biomarker Market Size Growth Rate by Type
1.4.2 Circulating DNA
1.4.3 Circulating Tumor Cells
1.4.4 Other
1.5 Market by Application
1.5.1 Global Circulating Biomarker Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Research Center
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Circulating Biomarker Market Size, Estimates and Forecasts
2.1.1 Global Circulating Biomarker Revenue 2015-2026
2.1.2 Global Circulating Biomarker Sales 2015-2026
2.2 Global Circulating Biomarker, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Circulating Biomarker Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Circulating Biomarker Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Circulating Biomarker Competitor Landscape by Players
3.1 Circulating Biomarker Sales by Manufacturers
3.1.1 Circulating Biomarker Sales by Manufacturers (2015-2020)
3.1.2 Circulating Biomarker Sales Market Share by Manufacturers (2015-2020)
3.2 Circulating Biomarker Revenue by Manufacturers
3.2.1 Circulating Biomarker Revenue by Manufacturers (2015-2020)
3.2.2 Circulating Biomarker Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Circulating Biomarker Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Circulating Biomarker Revenue in 2019
3.2.5 Global Circulating Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Circulating Biomarker Price by Manufacturers
3.4 Circulating Biomarker Manufacturing Base Distribution, Product Types
3.4.1 Circulating Biomarker Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Circulating Biomarker Product Type
3.4.3 Date of International Manufacturers Enter into Circulating Biomarker Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Circulating Biomarker Market Size by Type (2015-2020)
4.1.1 Global Circulating Biomarker Sales by Type (2015-2020)
4.1.2 Global Circulating Biomarker Revenue by Type (2015-2020)
4.1.3 Circulating Biomarker Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Circulating Biomarker Market Size Forecast by Type (2021-2026)
4.2.1 Global Circulating Biomarker Sales Forecast by Type (2021-2026)
4.2.2 Global Circulating Biomarker Revenue Forecast by Type (2021-2026)
4.2.3 Circulating Biomarker Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Circulating Biomarker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Circulating Biomarker Market Size by Application (2015-2020)
5.1.1 Global Circulating Biomarker Sales by Application (2015-2020)
5.1.2 Global Circulating Biomarker Revenue by Application (2015-2020)
5.1.3 Circulating Biomarker Price by Application (2015-2020)
5.2 Circulating Biomarker Market Size Forecast by Application (2021-2026)
5.2.1 Global Circulating Biomarker Sales Forecast by Application (2021-2026)
5.2.2 Global Circulating Biomarker Revenue Forecast by Application (2021-2026)
5.2.3 Global Circulating Biomarker Price Forecast by Application (2021-2026)
6 North America
6.1 North America Circulating Biomarker by Country
6.1.1 North America Circulating Biomarker Sales by Country
6.1.2 North America Circulating Biomarker Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Circulating Biomarker Market Facts & Figures by Type
6.3 North America Circulating Biomarker Market Facts & Figures by Application
7 Europe
7.1 Europe Circulating Biomarker by Country
7.1.1 Europe Circulating Biomarker Sales by Country
7.1.2 Europe Circulating Biomarker Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Circulating Biomarker Market Facts & Figures by Type
7.3 Europe Circulating Biomarker Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Circulating Biomarker by Region
8.1.1 Asia Pacific Circulating Biomarker Sales by Region
8.1.2 Asia Pacific Circulating Biomarker Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Circulating Biomarker Market Facts & Figures by Type
8.3 Asia Pacific Circulating Biomarker Market Facts & Figures by Application
9 Latin America
9.1 Latin America Circulating Biomarker by Country
9.1.1 Latin America Circulating Biomarker Sales by Country
9.1.2 Latin America Circulating Biomarker Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Circulating Biomarker Market Facts & Figures by Type
9.3 Central & South America Circulating Biomarker Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Circulating Biomarker by Country
10.1.1 Middle East and Africa Circulating Biomarker Sales by Country
10.1.2 Middle East and Africa Circulating Biomarker Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Circulating Biomarker Market Facts & Figures by Type
10.3 Middle East and Africa Circulating Biomarker Market Facts & Figures by Application
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Circulating Biomarker Products Offered
11.1.5 Abbott Laboratories Related Developments
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Corporation Information
11.2.2 Becton, Dickinson and Company Description and Business Overview
11.2.3 Becton, Dickinson and Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Becton, Dickinson and Company Circulating Biomarker Products Offered
11.2.5 Becton, Dickinson and Company Related Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Corporation Information
11.3.2 GE Healthcare Description and Business Overview
11.3.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GE Healthcare Circulating Biomarker Products Offered
11.3.5 GE Healthcare Related Developments
11.4 Epigenomics AG
11.4.1 Epigenomics AG Corporation Information
11.4.2 Epigenomics AG Description and Business Overview
11.4.3 Epigenomics AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Epigenomics AG Circulating Biomarker Products Offered
11.4.5 Epigenomics AG Related Developments
11.5 Agilent Technologies
11.5.1 Agilent Technologies Corporation Information
11.5.2 Agilent Technologies Description and Business Overview
11.5.3 Agilent Technologies Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Agilent Technologies Circulating Biomarker Products Offered
11.5.5 Agilent Technologies Related Developments
11.6 Biocept
11.6.1 Biocept Corporation Information
11.6.2 Biocept Description and Business Overview
11.6.3 Biocept Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biocept Circulating Biomarker Products Offered
11.6.5 Biocept Related Developments
11.7 Affymetrix
11.7.1 Affymetrix Corporation Information
11.7.2 Affymetrix Description and Business Overview
11.7.3 Affymetrix Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Affymetrix Circulating Biomarker Products Offered
11.7.5 Affymetrix Related Developments
11.8 Fluxion Biosciences
11.8.1 Fluxion Biosciences Corporation Information
11.8.2 Fluxion Biosciences Description and Business Overview
11.8.3 Fluxion Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Fluxion Biosciences Circulating Biomarker Products Offered
11.8.5 Fluxion Biosciences Related Developments
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Circulating Biomarker Products Offered
11.1.5 Abbott Laboratories Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Circulating Biomarker Market Estimates and Projections by Region
12.1.1 Global Circulating Biomarker Sales Forecast by Regions 2021-2026
12.1.2 Global Circulating Biomarker Revenue Forecast by Regions 2021-2026
12.2 North America Circulating Biomarker Market Size Forecast (2021-2026)
12.2.1 North America: Circulating Biomarker Sales Forecast (2021-2026)
12.2.2 North America: Circulating Biomarker Revenue Forecast (2021-2026)
12.2.3 North America: Circulating Biomarker Market Size Forecast by Country (2021-2026)
12.3 Europe Circulating Biomarker Market Size Forecast (2021-2026)
12.3.1 Europe: Circulating Biomarker Sales Forecast (2021-2026)
12.3.2 Europe: Circulating Biomarker Revenue Forecast (2021-2026)
12.3.3 Europe: Circulating Biomarker Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Circulating Biomarker Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Circulating Biomarker Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Circulating Biomarker Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Circulating Biomarker Market Size Forecast by Region (2021-2026)
12.5 Latin America Circulating Biomarker Market Size Forecast (2021-2026)
12.5.1 Latin America: Circulating Biomarker Sales Forecast (2021-2026)
12.5.2 Latin America: Circulating Biomarker Revenue Forecast (2021-2026)
12.5.3 Latin America: Circulating Biomarker Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Circulating Biomarker Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Circulating Biomarker Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Circulating Biomarker Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Circulating Biomarker Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Circulating Biomarker Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Circulating Biomarker Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Circulating Biomarker Market Segments
Table 2. Ranking of Global Top Circulating Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Circulating Biomarker Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Circulating DNA
Table 5. Major Manufacturers of Circulating Tumor Cells
Table 6. Major Manufacturers of Other
Table 7. Global Circulating Biomarker Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Circulating Biomarker Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Circulating Biomarker Sales by Regions 2015-2020 (K MT)
Table 10. Global Circulating Biomarker Sales Market Share by Regions (2015-2020)
Table 11. Global Circulating Biomarker Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Circulating Biomarker Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Circulating Biomarker Sales Share by Manufacturers (2015-2020)
Table 14. Global Circulating Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Circulating Biomarker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Biomarker as of 2019)
Table 16. Circulating Biomarker Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Circulating Biomarker Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Circulating Biomarker Price (2015-2020) (USD/MT)
Table 19. Circulating Biomarker Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Circulating Biomarker Product Type
Table 21. Date of International Manufacturers Enter into Circulating Biomarker Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Circulating Biomarker Sales by Type (2015-2020) (K MT)
Table 24. Global Circulating Biomarker Sales Share by Type (2015-2020)
Table 25. Global Circulating Biomarker Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Circulating Biomarker Revenue Share by Type (2015-2020)
Table 27. Circulating Biomarker Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Circulating Biomarker Sales by Application (2015-2020) (K MT)
Table 29. Global Circulating Biomarker Sales Share by Application (2015-2020)
Table 30. North America Circulating Biomarker Sales by Country (2015-2020) (K MT)
Table 31. North America Circulating Biomarker Sales Market Share by Country (2015-2020)
Table 32. North America Circulating Biomarker Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Circulating Biomarker Revenue Market Share by Country (2015-2020)
Table 34. North America Circulating Biomarker Sales by Type (2015-2020) (K MT)
Table 35. North America Circulating Biomarker Sales Market Share by Type (2015-2020)
Table 36. North America Circulating Biomarker Sales by Application (2015-2020) (K MT)
Table 37. North America Circulating Biomarker Sales Market Share by Application (2015-2020)
Table 38. Europe Circulating Biomarker Sales by Country (2015-2020) (K MT)
Table 39. Europe Circulating Biomarker Sales Market Share by Country (2015-2020)
Table 40. Europe Circulating Biomarker Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Circulating Biomarker Revenue Market Share by Country (2015-2020)
Table 42. Europe Circulating Biomarker Sales by Type (2015-2020) (K MT)
Table 43. Europe Circulating Biomarker Sales Market Share by Type (2015-2020)
Table 44. Europe Circulating Biomarker Sales by Application (2015-2020) (K MT)
Table 45. Europe Circulating Biomarker Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Circulating Biomarker Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Circulating Biomarker Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Circulating Biomarker Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Circulating Biomarker Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Circulating Biomarker Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Circulating Biomarker Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Circulating Biomarker Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Circulating Biomarker Sales Market Share by Application (2015-2020)
Table 54. Latin America Circulating Biomarker Sales by Country (2015-2020) (K MT)
Table 55. Latin America Circulating Biomarker Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Circulating Biomarker Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Circulating Biomarker Revenue Market Share by Country (2015-2020)
Table 58. Latin America Circulating Biomarker Sales by Type (2015-2020) (K MT)
Table 59. Latin America Circulating Biomarker Sales Market Share by Type (2015-2020)
Table 60. Latin America Circulating Biomarker Sales by Application (2015-2020) (K MT)
Table 61. Latin America Circulating Biomarker Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Circulating Biomarker Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Circulating Biomarker Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Circulating Biomarker Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Circulating Biomarker Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Circulating Biomarker Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Circulating Biomarker Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Circulating Biomarker Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Circulating Biomarker Sales Market Share by Application (2015-2020)
Table 70. Abbott Laboratories Corporation Information
Table 71. Abbott Laboratories Description and Major Businesses
Table 72. Abbott Laboratories Circulating Biomarker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Abbott Laboratories Product
Table 74. Abbott Laboratories Recent Development
Table 75. Becton, Dickinson and Company Corporation Information
Table 76. Becton, Dickinson and Company Description and Major Businesses
Table 77. Becton, Dickinson and Company Circulating Biomarker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Becton, Dickinson and Company Product
Table 79. Becton, Dickinson and Company Recent Development
Table 80. GE Healthcare Corporation Information
Table 81. GE Healthcare Description and Major Businesses
Table 82. GE Healthcare Circulating Biomarker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GE Healthcare Product
Table 84. GE Healthcare Recent Development
Table 85. Epigenomics AG Corporation Information
Table 86. Epigenomics AG Description and Major Businesses
Table 87. Epigenomics AG Circulating Biomarker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Epigenomics AG Product
Table 89. Epigenomics AG Recent Development
Table 90. Agilent Technologies Corporation Information
Table 91. Agilent Technologies Description and Major Businesses
Table 92. Agilent Technologies Circulating Biomarker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Agilent Technologies Product
Table 94. Agilent Technologies Recent Development
Table 95. Biocept Corporation Information
Table 96. Biocept Description and Major Businesses
Table 97. Biocept Circulating Biomarker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Biocept Product
Table 99. Biocept Recent Development
Table 100. Affymetrix Corporation Information
Table 101. Affymetrix Description and Major Businesses
Table 102. Affymetrix Circulating Biomarker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Affymetrix Product
Table 104. Affymetrix Recent Development
Table 105. Fluxion Biosciences Corporation Information
Table 106. Fluxion Biosciences Description and Major Businesses
Table 107. Fluxion Biosciences Circulating Biomarker Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Fluxion Biosciences Product
Table 109. Fluxion Biosciences Recent Development
Table 110. Global Circulating Biomarker Sales Forecast by Regions (2021-2026) (K MT)
Table 111. Global Circulating Biomarker Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Circulating Biomarker Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Circulating Biomarker Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Circulating Biomarker Sales Forecast by Country (2021-2026) (K MT)
Table 115. North America: Circulating Biomarker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Circulating Biomarker Sales Forecast by Country (2021-2026) (K MT)
Table 117. Europe: Circulating Biomarker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Circulating Biomarker Sales Forecast by Region (2021-2026) (K MT)
Table 119. Asia Pacific: Circulating Biomarker Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Circulating Biomarker Sales Forecast by Country (2021-2026) (K MT)
Table 121. Latin America: Circulating Biomarker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Circulating Biomarker Sales Forecast by Country (2021-2026) (K MT)
Table 123. Middle East and Africa: Circulating Biomarker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Circulating Biomarker Players
Table 128. Circulating Biomarker Customers List
Table 129. Circulating Biomarker Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Circulating Biomarker Product Picture
Figure 2. Global Circulating Biomarker Sales Market Share by Type in 2020 & 2026
Figure 3. Circulating DNA Product Picture
Figure 4. Circulating Tumor Cells Product Picture
Figure 5. Other Product Picture
Figure 6. Global Circulating Biomarker Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Medical Research Center
Figure 9. Others
Figure 10. Circulating Biomarker Report Years Considered
Figure 11. Global Circulating Biomarker Market Size 2015-2026 (US$ Million)
Figure 12. Global Circulating Biomarker Sales 2015-2026 (K MT)
Figure 13. Global Circulating Biomarker Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Circulating Biomarker Sales Market Share by Region (2015-2020)
Figure 15. Global Circulating Biomarker Sales Market Share by Region in 2019
Figure 16. Global Circulating Biomarker Revenue Market Share by Region (2015-2020)
Figure 17. Global Circulating Biomarker Revenue Market Share by Region in 2019
Figure 18. Global Circulating Biomarker Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Circulating Biomarker Revenue in 2019
Figure 20. Circulating Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Circulating Biomarker Sales Market Share by Type (2015-2020)
Figure 22. Global Circulating Biomarker Sales Market Share by Type in 2019
Figure 23. Global Circulating Biomarker Revenue Market Share by Type (2015-2020)
Figure 24. Global Circulating Biomarker Revenue Market Share by Type in 2019
Figure 25. Global Circulating Biomarker Market Share by Price Range (2015-2020)
Figure 26. Global Circulating Biomarker Sales Market Share by Application (2015-2020)
Figure 27. Global Circulating Biomarker Sales Market Share by Application in 2019
Figure 28. Global Circulating Biomarker Revenue Market Share by Application (2015-2020)
Figure 29. Global Circulating Biomarker Revenue Market Share by Application in 2019
Figure 30. North America Circulating Biomarker Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Circulating Biomarker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Circulating Biomarker Sales Market Share by Country in 2019
Figure 33. North America Circulating Biomarker Revenue Market Share by Country in 2019
Figure 34. U.S. Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Circulating Biomarker Market Share by Type in 2019
Figure 39. North America Circulating Biomarker Market Share by Application in 2019
Figure 40. Europe Circulating Biomarker Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Circulating Biomarker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Circulating Biomarker Sales Market Share by Country in 2019
Figure 43. Europe Circulating Biomarker Revenue Market Share by Country in 2019
Figure 44. Germany Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Circulating Biomarker Market Share by Type in 2019
Figure 55. Europe Circulating Biomarker Market Share by Application in 2019
Figure 56. Asia Pacific Circulating Biomarker Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Circulating Biomarker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Circulating Biomarker Sales Market Share by Region in 2019
Figure 59. Asia Pacific Circulating Biomarker Revenue Market Share by Region in 2019
Figure 60. China Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Circulating Biomarker Market Share by Type in 2019
Figure 83. Asia Pacific Circulating Biomarker Market Share by Application in 2019
Figure 84. Latin America Circulating Biomarker Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Circulating Biomarker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Circulating Biomarker Sales Market Share by Country in 2019
Figure 87. Latin America Circulating Biomarker Revenue Market Share by Country in 2019
Figure 88. Mexico Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Circulating Biomarker Market Share by Type in 2019
Figure 95. Latin America Circulating Biomarker Market Share by Application in 2019
Figure 96. Middle East and Africa Circulating Biomarker Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Circulating Biomarker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Circulating Biomarker Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Circulating Biomarker Revenue Market Share by Country in 2019
Figure 100. Turkey Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Circulating Biomarker Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Circulating Biomarker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Circulating Biomarker Market Share by Type in 2019
Figure 107. Middle East and Africa Circulating Biomarker Market Share by Application in 2019
Figure 108. North America Circulating Biomarker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Circulating Biomarker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Circulating Biomarker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Circulating Biomarker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Circulating Biomarker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Circulating Biomarker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Circulating Biomarker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Circulating Biomarker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Circulating Biomarker Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Circulating Biomarker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
リキッドバイオプシー用循環バイオマーカーの世界市場（～2026年） Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Circulating Biomarker for Liquid Bi…- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 循環腫瘍細胞（CTC）予後技術の世界市場（～2026年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 循環腫瘍細胞（CTC）の世界市場（～2026年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…
- 腫瘍バイオマーカー検査の世界市場（～2026年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Biomarker Test Scope and Market Size Tumor Biomarker Test market is…